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Abstract Purpose: Acute lung
injury is characterized by an exag-
gerated inﬂammatory response and a
high metabolic demand. Mechanical
ventilation can contribute to lung
injury, resulting in ventilator-induced
lung injury (VILI). A suspended-ani-
mation-like state induced by
hydrogen sulﬁde (H2S) protects
against hypoxia-induced organ injury.
We hypothesized that suspended ani-
mation is protective in VILI by
reducing metabolism and thereby
CO2 production, allowing for a lower
respiratory rate while maintaining
adequate gas exchange. Alternatively,
H2S may reduce inﬂammation in
VILI. Methods: In mechanically
ventilated rats, VILI was created by
application of 25 cmH2O positive
inspiratory pressure (PIP) and zero
positive end-expiratory pressure
(PEEP). Controls were lung-protec-
tive mechanically ventilated
(13 cmH2O PIP, 5 cmH2O PEEP).
H2S donor NaHS was infused con-
tinuously; controls received saline. In
separate control groups, hypothermia
was induced to reproduce the H2S-
induced fall in temperature. In VILI
groups, respiratory rate was adjusted
to maintain normo-pH. Results:
NaHS dose-dependently and revers-
ibly reduced body temperature, heart
rate, and exhaled amount of CO2.I n
VILI, NaHS reduced markers of pul-
monary inﬂammation and improved
oxygenation, an effect which was not
observed after induction of deep
hypothermia that paralleled the
NaHS-induced fall in temperature.
Both NaHS and hypothermia allowed
for lower respiratory rates while
maintaining gas exchange. Conclu-
sions: NaHS reversibly induced a
hypometabolic state in anesthetized
rats and protected from VILI by
reducing pulmonary inﬂammation, an
effect that was in part independent of
body temperature.
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Introduction
Acute lung injury (ALI) is a common complication in
critically ill patients [1], characterized by an exaggerated
inﬂammatory response, often requiring mechanical ven-
tilation. Mechanical ventilation itself, however, can
contribute to lung injury, called ventilator-induced lung
injury (VILI) [2]. Mechanisms of VILI include over-
stretchingandrepetitiveopeningandclosingofthealveoli,
leading to a pro-inﬂammatory state [3]. Mechanical and
inﬂammatory processes probably interact: a mechanically
stressed lung may produce an inﬂammatory reaction [4].
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mechanical stress [5].
Reducing mechanical stress by applying low tidal
volumes reduces mortality in ALI patients [6]. Besides
restrictive volume ventilation, lowering of respiratory
frequency attenuated ALI in experimental models [7].
Although (mild) respiratory acidosis has been shown to
decrease mortality in ALI [8], severe acidosis is usually
avoided. Respiratory acidosis can compromise immune
function [9] and right ventricular function [10] and
decrease oxygenation [11]. Also, use of tidal volumes
lower then 6 ml/kg was found to enhance lung protection
[12], calling for new interventions that allow for low
minute ventilation while maintaining adequate gas
exchange. A hypometabolic state, with decreased CO2
production, was induced in mice using hydrogen sulﬁde
(H2S) gas [13]. H2S inhibits cytochrome c oxidase,
thereby blocking oxidative phosphorylation, leading to
decreased oxygen consumption. The mice experienced a
drop in body temperature, heart rate, and CO2 production,
resembling a state akin to hibernation. This was termed a
‘‘suspended-animation-like state.’’ H2S has also anti-
inﬂammatory effects, including inhibition of cytokine
production and neutrophil function and inﬂux [14–17].
Herein, we describe the induction of a suspended-ani-
mation-like state in a physiological in vivo VILI model,
usinganintravenousH2Sdonor.WehypothesizedthatH2S-
induced hypometabolism protects from VILI by reducing
inﬂammation.Alternatively,H2S-inducedhypometabolism
may lower CO2 production, thereby allowing for a lower
respiratory rate and hence less VILI. Distinguishing
betweenthesedifferenteffectsmayinﬂuence futurestudies
on VILI, redirecting efforts on reducing minute ventilation
to interventions targeting inﬂammation, or vice versa.
Methods
H2S donor
Preparations of a H2S donor were made freshly on the day
of the experiments. NaHS (Sigma-Aldrich, Steinheim,
Germany) was diluted in distilled water to a stock solution
(90 mM), and pH adjusted to 7.5 using KCl. Further dilu-
tionsweremadebyuncappingthecontainerandimmediate
loadingofthesyringewithNaHS,dilutedwithsaline0.9%.
Anesthesia and instrumentation
The study was approved by the animal care and use
committee of our hospital. Male Sprague–Dawley rats
(±350 g; Harlan, The Hague, The Netherlands) received
an intraperitoneal injection of anesthesia mix (0.15 ml/
100 g body weight) containing 90 mg/kg ketamine,
0.5 mg/kg medetomidine, and 0.05 mg/kg atropine.
Anesthesia was maintained by infusion of 50 mg/kg ket-
amine at 0.5 ml/100 g/h. Tracheotomy was performed,
after which a metal cannula was connected to a ventilator
(Servo 900C; Siemens, Sweden). Hemodynamic moni-
toring was done by a carotid artery catheter connected to a
monitor. Aortic ﬂow was measured by insertion of a ﬂow
probe (T106; Transonic System, NY, USA) around the
ascending aorta following thoracotomy. Mean stroke
volume was calculated by dividing the heart rate by the
aortic ﬂow. Arterial blood gas analysis was performed
hourly (alpha-stat, Rapidlab 865 blood gas analyzer;
Bayern, Mijdrecht, The Netherlands). In the saline control
groups, rectal temperature was maintained at 37C.
VILI and lung-protective mechanical ventilation
Rats were ventilated for 4 h in a pressure-controlled mode
with 25 cmH2O positive inspiratory pressure (PIP) and
0 cmH2O positive end-expiratory pressure (PEEP) (tidal
volume *15 ml/kg), thereby creating VILI [5]. Lung-
protective (LP) mechanical ventilation was achieved by
13 cmH2O PIP and 5 cmH2O PEEP (tidal volume
*7.5 ml/kg). FiO2 was set at 60% and I:E ratio at 1:2. In
VILI groups, respiratory rate was adjusted according to
blood gas analysis to maintain normo-pH. End-tidal (et)
CO2 was measured by carbon dioxide analyzer (CWE
Inc., Ardmore, PA, USA).
Experimental protocol
A dose-ﬁnding experiment was performed with 18, 36,
and 72 lmol/kg/h NaHS (n = 8 per group). For further
experiments, a dose of 36 lmol/kg/h was used. Ran-
domization to lung-injurious mechanical ventilation or to
LP mechanical ventilation was done, followed by NaHS
or saline infusion (n = 8 per group). As suspended ani-
mation is accompanied by hypothermia, additional
control groups were used, in which animals were actively
cooled to reproduce the H2S-induced fall in temperature,
by placing ice bags on the belly.
Bronchoalveolar lavage, tissue sampling, and analyses
After 4 h of mechanical ventilation, the rats were bled.
The right lung was ligated. Bronchoalveolar lavage ﬂuid
(BALF) was obtained by ﬂushing the left lung (3 9 2m l
saline). Cell counts were determined using a hematocy-
tometer (Z2 Coulter Particle Counter; Beckman Coulter,
FL, USA). Differential counts were done on Giemsa-
stained cytospins. Hematoxylin and eosin-stained lung
sections were analyzed by a pathologist who was blinded
to group identity. Edema, hemorrhage, inﬁltration, wall
1947thickness, and hyperinﬂation were scored on a scale of
0–4: 0 for normal lungs, 1 for\25% lung involvement, 2
for 25–50% involvement, 3 for 50–75% involvement, and
4 for[75% lung involvement. Total histology score is the
sum score of all parameters. The remaining right lobes
were weighed to determine wet weight. Interleukin (IL)-6,
cytokine-induced neutrophil chemoattractant 3 (CINC3),
tumor necrosis factor (TNF), and IL-1b were measured by
enzyme-linked immunosorbent assay (ELISA) according
to instructions from the manufacturer (R&D Systems,
Abingdon, UK) as were protein levels in BALF (Brad-
ford; Oz Biosciences, Marseille, France).
Rat behavior after hydrogen sulﬁde infusion
Behavioral studies were performed in six additional
intubated rats. NaHS was infused at 36 lmol/kg/h for 4 h.
After stopping the infusion, animals were rewarmed and
extubated. Behavior was monitored hourly for 8 h by
observational assessment of movement, signs of stress,
eating and drinking, as well as physiological parameters
including breathing pattern and frequency and heart rate
[18]. During 15 min of observation, the presence of
anxiety (arched back, raised fur), locomotor activity
(attempt to stand or any other movement), and food or
water intake (each attempt to drink or eat) were scored as
present (1 point) or not present (0 points).
Statistical analysis
Data are expressed as mean with standard deviation (SD),
or as mean with standard error of the mean (SEM) in the
ﬁgures. Intergroup differences were analyzed by analysis
of variance (ANOVA) and Bonferroni’s post hoc test, or
by Kruskal–Wallis test with Mann–Whitney U test
according to the data distribution. A p value of\0.05 was
consideredsigniﬁcant.Statisticalanalysesweredoneusing
Prism (Graphpad Prism 5, CA, USA) and SPSS version 15
(SPSS Inc., IL, USA).
Results
Hydrogen sulﬁde dose-dependently induced
physiological changes consistent with a
suspended-animation-like state in anesthetized
rats and reduced exhaled CO2
NaHS at 36 lmol/kg/h reduced body temperature from
36.4 ± 0.8C to 25.7 ± 1.5C( p\0.05) and heart rate
from 289 ± 33 to 136 ± 33 beats/min (p\0.05).
Increasing the dose to 72 lmol/kg/h showed similar
effects. However, in this group, two animals died within
2 h, indicating possible toxicity. When a lower dose of
18 lmol/kg/h was used, changes in body temperature and
heart rate were less profound (from 37.0 ± 1.0Ct o
27.9 ± 1.3C and from 291 ± 28 to 178 ± 61 beats/min,
respectively; p\0.05 versus 2 mg/kg/h). For all further
experiments, a dose of 36 lmol/kg/h was used.
Infusion of NaHS increased stroke volume from
118 ± 14 ll at baseline to 173 ± 5 ll( p\0.05) after
4 h. Cardiac output did not change (330 ± 170 versus
195 ± 60 ll/min, p = 0.08). Hydrogen sulﬁde reduced
exhaled CO2 by *33% after 4 h of infusion compared
with baseline (p\0.05), whereas hypothermia resulted in
a *16% reduction (Table 1).
Effect of NaHS on body temperature
and hemodynamics in a VILI model
Similar to the preliminary experiments, H2S donor NaHS
induced physiologic changes akin to hibernation, reducing
Table 1 Respiratory parameters during hydrogen sulﬁde donor NaHS infusion and induced hypothermia in a mechanically ventilated
model of ventilator-induced lung injury (VILI), at baseline (T = 0) and after 4 h of mechanical ventilation (T = 4)
Time (h) LP VILI
Saline NaHS Hypothermia Saline NaHS Hypothermia
pH T = 0 7.33 ± 0.14 7.38 ± 0.07 7.43 ± 0.08 7.47 ± 0.07 7.41 ± 0.06 7.47 ± 0.05
T = 4 7.28 ± 0.14 7.41 ± 0.03 7.36 ± 0.09 7.46 ± 0.06 7.42 ± 0.10 7.43 ± 0.11
PaCO2 (kPa) T = 0 5.3 ± 1.5 5.4 ± 1.0 4.6 ± 0.4 4.2 ± 0.6 5.0 ± 0.7 4.0 ± 0.8
T = 4 6.0 ± 1.7 4.8 ± 1.4 4.9 ± 1.4 2.8 ± 0.5 3.8 ± 1.1 4.5 ± 1.4
PaO2 (kPa) T = 03 6 ± 53 6 ± 33 7 ± 53 8 ± 44 0 ± 23 6 ± 4
T = 44 0 ± 45 3 ± 3
a 44 ± 84 1 ± 24 8 ± 2
b 32 ± 16
HCO3
- (mmol/l) T = 02 4 ± 42 3 ± 42 2 ± 32 3 ± 32 3 ± 22 2 ± 2
T = 42 1 ± 42 1 ± 32 0 ± 21 6 ± 21 8 ± 32 2 ± 3
Respiratory rate T = 03 5 ± 03 5 ± 03 5 ± 03 5 ± 03 5 ± 03 5 ± 0
T = 43 6 ± 23 5 ± 03 5 ± 02 1 ± 21 6 ± 1
b 18 ± 1
End-tidal CO2 T = 0 5.1 ± 0.9 5.2 ± 1.0 3.8 ± 1.2 4.0 ± 1.0 4.8 ± 1.0 3.1 ± 0.9
T = 4 5.6 ± 1.2 3.3 ± 0.5
a 3.2 ± 1.5
c 2.6 ± 1.4 3.4 ± 1.0 2.0 ± 0.2
Data are means ± SD. LP lung-protective mechanical ventilation
a LP saline versus LP ? NaHS
b VILI saline versus VILI ? NaHS
c LP saline versus LP ? hypothermia
1948body temperature and heart rate compared with saline
controls (Electronic Supplementary Material, Fig. 1, both
p\0.05).Inthehypothermiacontrolgroups,activecooling
was necessarytoreachbodytemperatures similartoNaHS-
treatedanimals.Inducedhypothermiaresultedinadecrease
in heart rate (Fig. 1). During the 4 h of mechanical venti-
lation, blood pressure did not drop in all groups.
Effect of suspended animation on pulmonary
inﬂammation in a VILI model
VILI was characterized by an increase in pulmonary wet
weight compared with lung-protective mechanical venti-
lation (p\0.05, Table 2), accompanied by an increase in
BALFcellcount andproteinlevels(p\0.05 forall).VILI
alsoresultedinincreasedBALFlevelsofIL-6,CINC3,and
neutrophil inﬂux compared with lung-protective mechani-
cally ventilated controls (IL-6: 824 ± 437 versus 31 ± 0
ng/ml, CINC3: 230 ± 47 versus 51 ± 44 pg/ml, neutro-
phils: 59 ± 22% versus 22 ± 14%, p\0.05, Fig. 1).
LevelsofTNFand IL-1bwere belowdetectionlimitsinall
groups. Histopathology showed more neutrophil inﬂux,
alveolar edema, and cellwall thickeninginVILIcompared
with lung-protective ventilated controls (p\0.05,
Table 2; Fig. 2, Electronic Supplementary Material).
NaHS reduced BALF neutrophil inﬂux in VILI
(59 ± 22% versus 28 ± 20%, p\0.05, Fig. 1), with a
decrease in BALF CINC3 levels (230 ± 47.3 versus
81.6 ± 34.8 pg/ml, p\0.05) and a tendency to decrease
IL-6 levels (824 ± 437 versus 336 ± 360 ng/ml, Fig. 1,
p = 0.07). NaHS improved histopathologic abnormalities
(p\0.05, Table 2; Fig. 2). Pulmonary edema, cell inﬂux,
and protein levels were nonsigniﬁcantly reduced, which
may have been due to large variations within the groups.
Effect of hypothermia on pulmonary inﬂammation
in a VILI model
To determine whether the protective effect of NaHS was
mediated by a reduction in body temperature, hypothermia
was induced to a temperature that paralleled the H2S
effect. Pulmonary inﬂammation in VILI did not decrease
by active cooling to a body temperature comparable to the
NaHS group. None of the inﬂammatory parameters in
VILI were reduced by hypothermia (Table 2; Fig. 1).
Effect of suspended animation on respiratory rate
and gas exchange in a VILI model
As expected, the respiratory rate in animals with VILI had
to be reduced during the experiment to maintain normo-
pH in a physiological VILI model (Table 1). Both NaHS-
treated animals and hypothermic controls allowed for a
more profound reduction in respiratory rate compared
with saline controls (p\0.05 for both). Adequate oxy-
genation was maintained in all groups. An increase in pO2
was observed in all groups treated with H2S compared
with saline controls (p\0.05 for both), an effect that was
not observed in the hypothermia groups.
Reversibility of suspended animation induced
by an H2S donor
To be of potential therapeutic interest, H2S-induced
effects need to be reversible. Therefore, we conducted a
behavioral experiment in six intubated animals. Compa-
rable to the previous results, NaHS reduced body
temperature from 37 ± 0.1Ct o2 9± 0.5C and heart
rate from 297 ± 29 to 217 ± 28 beats/min. etCO2
decreased by 38 ± 4% compared with baseline
(p\0.05). After cessation of NaHS and active rewarm-
ing, heart rate and etCO2 values returned to baseline
within 30 min. After cessation of anesthesia, animals
awoke and were extubated. During the ﬁrst 4 h, animals
lay calmly in their cages with normal breathing pattern.
Gradually, the animals started moving, drinking, and
eating. After 8 h of observation, the rats showed no
behavioral abnormalities (Table 3, Electronic Supple-
mentary Material).
Table 2 Effect of hydrogen sulﬁde donor NaHS and induced hypothermia on cell inﬂux and protein concentrations in bronchoalveolar
lavage ﬂuid, pulmonary wet weight, and lung pathology scores in ventilator-induced lung injury (VILI)
LP VILI
Saline NaHS Hypothermia Saline NaHS Hypothermia
Lung wet weight (mg) 750 ± 116 784 ± 111 669 ± 101 967 ± 82
a 896 ± 117 1,206 ± 309
Cell count (910
4 cells/ml) 13.4 ± 13 23.3 ± 21 35.6 ± 10 83.9 ± 47.9
a 41.7 ± 40 129 ± 149
Protein (lg/ml) 274 ± 185 373 ± 88.4 341 ± 186 658 ± 26
a 448 ± 174 769 ± 355
Pathology score 1.3 ± 1.0 2.0 ± 0.9 1.1 ± 0.4 4.2 ± 1.0
a 2.8 ± 0.8
b 3.6 ± 1.1
Data are means ± SD. LP lung-protective mechanical ventilation
a LP saline versus VILI saline
b VILI saline versus VILI ? NaHS
1949Discussion
In the present study, an intravenous H2S donor reversibly
induced a suspended-animation-like state in anesthetized
and mechanically ventilated rats. NaHS reduced pulmon-
ary injury caused by the mechanical ventilator by reducing
pulmonary inﬂammation, an effect which was independent
of a mere reduction in body temperature. As both NaHS
and hypothermia allowed for lower respiratory rates,
reduction of respiratory rate did not contribute to the
observed protective effect of NaHS in our VILI model.
H2S gas can induce a suspended-animation-like state
in mammals that do not normally hibernate [13, 19, 20].
In the present study, we show that H2S donor NaHS in
anesthetized rats induced comparable physiological
changes. Also, NaHS reduced the amount of exhaled CO2
(etCO2) at unchanged ventilator settings. We did not
measure CO2 production. However, as a fall in CO2
delivery to the lungs is unlikely to account for the
observed decrease in etCO2 at unchanged cardiac output
and unchanged minute ventilation, the decrease in etCO2
may indicate decreased metabolic rate in this model. Use
of a parenteral solution instead of gas has practical
advantages, as there is no need for an inhalation device
system and less risk of exposure to the gas.
We found that NaHS attenuated lung injury in an
in vivo VILI model by inhibiting inﬂammatory processes.
NaHS decreased pulmonary neutrophil inﬂux, with a
decrease in chemokine CINC3 levels. A recent experi-
ment using H2S gas in a mice model of VILI also found a
reduction in extravasation of neutrophils and neutrophil
apoptosis [21]. As inﬂux of neutrophils is a hallmark of
acute lung injury, H2S-induced suspended animation may
also be beneﬁcial in other causes of lung injury. In
addition, we found that NaHS reduced levels of the pro-
inﬂammatory cytokine IL-6 in VILI. Comparably, in
models of lung injury, bolus treatment with H2S reduced
levels of IL-1 and IL-8 and increased levels of IL-10 [14].
The anti-inﬂammatory properties of H2S have also been
shown after inhibition of endogenously produced H2S
[22]. However, endogenously produced H2S also medi-
ated inﬂammation during experimental endotoxemia [23],
suggesting a dual role of H2S in inﬂammation. In our
study, hibernating doses of NaHS reduced inﬂammation,
which may be mediated by a reduction in neutrophil
inﬂux at the site of injury.
As mild hypothermia has been found to reduce inﬂam-
mationinVILI[24,25],wedeterminedwhethertheNaHS-
induced reduction in inﬂammatory parameters in our study
was due to a reduction in body temperature. We found that
animals needed to be actively cooled to reproduce the
NaHS-inducedfallintemperature,whichwasnotachieved
by merely switching off the heating pad. This suggests that
the profound reduction of body temperature is a speciﬁc
effectofNaHS.Inaddition,althoughhypothermiareduced
metabolism, it did not protect from lung injury. This
accords with ﬁndings in a mice VILI model, in which H2S
reduced lung injury, but mild hypothermia did not [21]. In
theseexperiments,ﬁxedbodytemperaturespresumablydid
not allow for a reduction in metabolism, as blood gas
analysis did not change during H2S inhalation and a
reduction in heart rate was not mentioned. Therefore, pro-
tection by H2S occurred via reduction of inﬂammation. In
thisstudy,itisnotclearwhethertheprotectiveeffectofH2S
Fig. 1 Interleukin-6 (a) and chemokine CINC3 (b) concentrations,
and neutrophil inﬂux (c) in bronchoalveolar lavage ﬂuids of
animals treated with hydrogen sulﬁde donor NaHS, saline and
hypothermic controls, mechanically ventilated with either lung-
protective (LP) or lung-injurious mechanical ventilation, creating
ventilator-induced lung injury (VILI). Data are mean ± SEM. * LP
versus VILI, p\0.05;
 VILI versus VILI ? NaHS, p\0.05
(n = 8 per group)
1950occurred mainly via reduction of metabolic rate or via
reduction of inﬂammation. Interestingly, H2S has an effect
on mitochondrial structure and function [26]. Also, H2S,
but not hypothermia, changes substrate utilization [27],
suggesting a distinct effect on metabolism. This issue
warrants further exploration.
Besides tidal volume, the repetitive strain of respira-
tory cycles may contribute to lung injury. In this study,
both NaHS and hypothermia allowed for lower respiratory
rates compared with controls. As lowering respiratory
rates did not decrease injury in the hypothermia group,
reduction of tachytrauma may not have contributed to the
protective effect of NaHS. In contrast, a reduction in
respiratory frequency reduced injury in an isolated per-
fused model of VILI [7]. Differences may be related to
different study designs, as compliance in ex vivo VILI
models is altered. Also, importantly, the reduction in our
model was only modest. Furthermore, in our physiological
VILI model, study groups did not allow for differentiation
between effects of hypothermia and low respiratory rate. It
is possible that a potential beneﬁcial effect of reducing
respiratory rate was counteracted by the deleterious effect
of profound hypothermia on lung tissue.
In contrast to the effect of H2S gas in a mice model of
VILI [21], NaHS improved oxygenation in our VILI
model. These contrasting results may relate to the dif-
ferent compound used. Notably, we analyzed blood gases
without temperature correction, which presumably results
in preservation of intracellular enzymes and other protein
structures. However, as the increase in oxygenation was
not found in hypothermic controls, it seems unlikely that a
shift in oxyhemoglobin dissociation curve caused by
hypothermia during suspended animation contributed to
the observed increased oxygenation [28].
The present study does not address several important
issues related to H2S-induced hypometabolism. Reducing
metabolism in small animals has important limitations,
because body temperature is reduced much faster [29]. Of
note, in larger animals including piglets and sheep, H2S
gas failed to induce a suspended-animation-like state
[30, 31]. However, H2S donor NaHS reduced body tem-
perature, O2 uptake, and CO2 production in a pig model of
ischemia–reperfusion injury, indicative of a reduction of
metabolism [32]. Whether reducing metabolism with the
appropriate compound is feasible in naturally nonhiber-
nating mammals remains to be determined in dose-ﬁnding
studies that induce hibernation-like states without induc-
ing toxicity in appropriately sized animal models.
As discussed, H2S and H2S donors may exert inﬂam-
matory and toxic effects, limiting applicability. There was
a nonsigniﬁcant increase in pulmonary cell inﬂux, wet
weight, protein levels, and cytokine levels in the lung-
protective control group compared with saline controls,
which may indicate a possible toxic effect. Obviously,
this issue warrants further investigation. A ﬁnal limitation
of the study is that we did not measure H2S content,
rendering the exact dose of H2S given unknown.
Conclusions
An intravenous H2S donor reversibly induced physiologic
changes consistent with a suspended-animation-like state
in anesthetized and mechanically ventilated rats. NaHS
protected from VILI by reducing inﬂammation, an effect
that was, at least in part, independent of body tempera-
ture. Reducing metabolism may be a new therapeutic
approach to protect the lungs from ventilator-associated
lung injury.
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